US Food and Drug Administration Approval of Aducanumab—Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?
Vincent Planche, Nicolas Villain
Abstract
International audience
Topics & Concepts
MedicineFood and drug administrationNeurologyOtorhinolaryngologyFamily medicinePsychiatryMedical emergencyAlzheimer's disease research and treatmentsHealth Systems, Economic Evaluations, Quality of LifeDementia and Cognitive Impairment Research